Pharma Industry

How India can rejig its science and healthcare research regime, and why the time to do it is now.



Despite considerable policy push, India has not been able to achieve a breakthrough as an academic powerhouse. This is an opportune time for the country to reboot a hybrid model of industry and university-based research. It will help if policymakers take a look at how countries like the US have been pulling it off.

There are several theories on the origin of the novel coronavirus. As the world awaits a vaccine with a bated breath, the pandemic has brought several home truths to the foreground — India’s chronic under-investment in medical infrastructure and the need for reforms in medical education to name a few.Despite being a tongue-twister, a relatively unknown drug, hydroxychloroquine, has entered the popular lexicon. But the fact remains that India,

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise


Source link